Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
About this item
Full title
Author / Creator
Curry, Michael P , O’Leary, Jacqueline G , Bzowej, Natalie , Muir, Andrew J , Korenblat, Kevin M , Fenkel, Jonathan M , Reddy, K. Rajender , Lawitz, Eric , Flamm, Steven L , Schiano, Thomas , Teperman, Lewis , Fontana, Robert , Schiff, Eugene , Fried, Michael , Doehle, Brian , An, Di , McNally, John , Osinusi, Anu , Brainard, Diana M , McHutchison, John G , Brown, Robert S , Charlton, Michael and ASTRAL-4 Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this phase 3 study involving patients with HCV genotype 1, 2, 3, 4, or 6 and decompensated cirrhosis, sofosbuvir–velpatasvir with or without ribavirin for 12 weeks or sofosbuvir–velpatasvir for 24 weeks resulted in high rates of sustained virologic response.
The number of patients with decompensated cirrhosis caused by chronic infection with...
Alternative Titles
Full title
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
Authors, Artists and Contributors
Author / Creator
O’Leary, Jacqueline G
Bzowej, Natalie
Muir, Andrew J
Korenblat, Kevin M
Fenkel, Jonathan M
Reddy, K. Rajender
Lawitz, Eric
Flamm, Steven L
Schiano, Thomas
Teperman, Lewis
Fontana, Robert
Schiff, Eugene
Fried, Michael
Doehle, Brian
An, Di
McNally, John
Osinusi, Anu
Brainard, Diana M
McHutchison, John G
Brown, Robert S
Charlton, Michael
ASTRAL-4 Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1752797055
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1752797055
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1512614
